低能量胸腰椎骨折后骨健康药物治疗现状
这项回顾性队列研究纳入2015至2021年在同一医疗系统四家中心治疗的低能量A型胸腰椎骨折患者,年龄≥50岁,共409例有完整数据和90天随访。仅41例(10%)在伤后90天内成功启动骨健康药物治疗;多因素分析显示手术治疗是唯一与治疗启动显著相关的因素(OR 3.35,95%CI 1.42-7.58,P=0.003)。
要点
- 低能量胸腰椎骨折后90天内成功启动骨健康治疗者仅占10%。
- 手术治疗与骨健康药物治疗启动独立相关,OR为3.35。
- 脊柱外科医生主动参与可提高患者接受骨健康药物的可能性。
核心结论
- 低能量胸腰椎骨折后适当的骨质疏松治疗在本队列中不常见,仅10%的患者成功启动治疗。
- 脊柱外科医生的主动参与增加了患者接受骨健康药物的可能性,可能成为改善患者照护的可推广干预措施。
研究设计与样本
- 回顾性队列研究,纳入2015至2021年在单一系统内四家医疗中心治疗的低能量A型胸腰椎骨折患者,年龄50岁及以上。
- 共409例患者具有完整数据和90天随访,从病历中提取临床、影像学、社会人口学和用药数据。
- 采用双变量统计和多因素logistic回归分析,调整潜在混杂因素后识别与成功骨质疏松治疗相关的因素。
主要发现
- 409例患者中仅41例(10%)成功启动骨健康药物治疗。
- 双变量和多变量分析中,手术治疗是唯一与骨健康治疗显著相关的因素。
- 接受手术治疗的患者接受骨质疏松治疗的比值增加超过3倍(OR:3.35,95%CI:1.42-7.58,P=0.003)。
关键数值与推荐
- 成功治疗定义为伤后90天内新启动骨健康治疗、在原有骨质疏松方案中新增骨健康药物或在抗骨质疏松药物之间更换。
- 纳入对象为50岁及以上、因低能量创伤导致A型胸椎或腰椎骨折的患者。
临床怎么用
- 对50岁及以上低能量胸腰椎骨折患者,应主动评估并启动骨健康药物治疗,而非仅处理骨折本身。
- 脊柱外科医生在诊疗流程中主动参与骨健康管理,可能提高骨质疏松治疗率。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY DESIGN: Retrospective cohort study. OBJECTIVE: To characterize the success rate of anti-osteoporosis treatment for patients with spine fracture that otherwise confers eligibility for treatment. We also evaluated factors associated with successful initiation of treatment. SUMMARY OF BACKGROUND DATA: Thoracic and lumbar spine fractures in patients 50 years of age or older after low-energy injuries confer a diagnosis of osteoporosis and indicate eligibility for bone health treatment. Despite this, there is little information available regarding the extent to which these patients receive appropriate treatment and the underlying factors that influence this decision. MATERIALS AND METHODS: We included patients 50 years of age or older treated at one of four medical centers within a single system for type A thoracic or lumbar spine fractures from low-energy trauma between 2015 and 2021. Clinical, radiographic, sociodemographic, and medication data were abstracted from the medical record. Patients were noted to have successful treatment if they had de novo initiation of bone health treatment, addition of a new bone health agent to a prior osteoporosis regimen, or switched between anti-osteoporosis agents within 90 days (90 d) of injury. Bivariate statistics and logistic multivariable regression were utilized to identify factors associated with successful osteoporosis treatment while adjusting for potential confounders. RESULTS: In total, 409 patients with complete data and 90 days of follow-up were included. Only 41 (10%) patients had successful treatment initiation of bone health medications. In both bivariate and multivariable analyses, surgical intervention was the only factor significantly associated with bone health treatment. Patients treated with surgery demonstrated a more than 3-fold increase in the odds of receiving osteoporosis treatment (OR: 3.35, 95% CI: 1.42-7.58, P =0.003). CONCLUSION: Appropriate osteoporosis treatment after low-energy spine fracture was uncommon in our cohort, occurring in just 10% of patients. Active engagement on the part of spine surgeons increased the likelihood of receipt of bone health medications. This may represent a scalable intervention that can improve patient care. LEVEL OF EVIDENCE: Level III.
引用
- Striano BM, Crawford AM, Holly KE, et al. Bone Health Medication Following Low Energy Thoracic and Lumbar Fractures. Spine (Phila Pa 1976). 2026. PMID: 41549712. doi:10.1097/BRS.0000000000005630
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。